Form 4: GE HealthCare Director H Lawrence Culp Jr. Reports Acquisition of Restricted Stock Units

H Lawrence Culp Jr., a director at GE HealthCare Technologies Inc., reported the acquisition of 2,440 restricted stock units.

Summary

• On May 21, 2024, H Lawrence Culp Jr., a director of GE HealthCare Technologies Inc., acquired 2,440 restricted stock units.
• These restricted stock units will vest on the earlier of GE HealthCare's next annual meeting of stockholders or May 21, 2025.
• Each restricted stock unit represents the right to receive one share of GE HealthCare common stock at settlement.
• Culp directly owns 624,074 shares of GE HealthCare common stock.
• Culp indirectly owns 1,271 shares through family trusts and 70,402 shares through a holding company.

Sentiment

Score: 6

Explanation: The sentiment is neutral as it's a standard regulatory filing detailing stock transactions by a company director. The acquisition of restricted stock units can be seen as a slightly positive sign, indicating confidence in the company's future.

Positives

• The acquisition of restricted stock units by a director signals confidence in the company's future performance.

Future Outlook

The restricted stock units will vest on the earlier of GE HealthCare's next annual meeting of stockholders or May 21, 2025, indicating a potential future increase in Culp's holdings of GE HealthCare common stock.

Industry Context

Form 4 filings are routine disclosures required by the SEC to provide transparency into the transactions of company insiders, allowing investors to track ownership changes and potential alignment of interests between management and shareholders.

Stakeholder Impact

• The transaction provides transparency to shareholders regarding the director's holdings and alignment with company performance.

Key Dates